(S) -STO021
(S) -STO021 is a highly selective, orally effective ERβ agonist. (S) -STO021 has a dual activity of inhibiting osteoclast activity and promoting osteoblast activity. (S) -STO021 can be used for research on osteoporosis[1].
Product Specifications
CAS Number
3058379-08-8
UNSPSC
12352128
Target
Estrogen Receptor/ERR
Related Pathways
Vitamin D Related/Nuclear Receptor
Field of Research
Inflammation/Immunology
Smiles
O=P(OCC)(OCC)OC1=CC=C(C=C1)[C@@H]2C(C3=CC(O)=CC(O)=C3)=C(OP(OCC)(OCC)=O)C4=CC(O)=CC(O)=C24
Molecular Formula
C29H34O12P2
Molecular Weight
636.52
References & Citations
[1]Peng C, et al. Discovery of Novel Selective Estrogen Receptor β (SERβ) Agonist (S) -STO021 as an Antiosteoporosis Candidate with Dual Functions of Inhibiting Osteoclastogenesis and Activating Osteoblastogenesis. J Med Chem. 2025 Nov 13;68 (21) :22715-22737.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
IGGSWBK3E50ML 50 mL
Innovative Grade US Origin Goose Whole Blood K3 EDTA 50ml
Sign In for Pricing
View Details 
MBS9020799-01 0.02 mg (E-Coli)
Recombinant Human Matrix metalloproteinase-25 (MMP25)
Sign In for Pricing
View Details MBS9020799-02 0.1 mg (E-Coli)
Recombinant Human Matrix metalloproteinase-25 (MMP25)
Sign In for Pricing
View Details